Big share of funds for kids' jabs not spent: RTI data

NEW DELHI: Even arsenic India allocates thousands of crores of rupees annually for kid vaccination, RTI information shows that a important stock of funds remains unspent, raising questions implicit implementation successful 1 of the country's largest nationalist wellness strategy - National Immunisation Programme. Under the programme - which provides escaped vaccines to support children against aggregate diseases, including polio, measles and hepatitis B - allocations person risen to implicit Rs 3,400 crore successful 2025-26, but spending has consistently lagged behind. In 2023-24, astir Rs 2,250 crore was utilised against the Rs 3,232-crore approved, portion successful 2024-25, expenditure dropped to astir Rs 1,971 crore against the Rs 3,186-crore sanctioned. For fiscal twelvemonth 2025-26, lone astir Rs 1,060 crore was spent - information till Dec and marked provisional - retired of the Rs 3,434-crore approved. The information is based connected fiscal monitoring reports submitted by states and UTs. Despite this, the programme continues to run astatine scale. Govt information showed that 2.3 crore to 2.5 crore children were vaccinated annually betwixt 2021-22 and 2024-25. Full immunisation sum has improved from 88.2% successful 2021-22 to 98.1% successful 2024-25, though it dipped somewhat successful 2023-24, information showed.

RTI activistic Amit Gupta said the programme is captious for protecting children and requires efficient, transparent usage of funds with beardown accountability. He besides urged govt to grow sum to see vaccines for influenza, typhoid and hepatitis, saying these are present indispensable for broad kid protection. However, the RTI effect besides points to gaps successful information systems. Gender-wise vaccination figures were not provided and were alternatively referred to different division, indicating fragmented record-keeping. Vaccines are sourced from a web of nationalist and backstage manufacturers, including Serum Institute of India, Bharat Biotech, Biological E and Indian Immunologicals.